New Releases from NCBI BookshelfInsulin Icodec (Awiqli): CADTH Reimbursement Recommendation: Indication: For the once-weekly treatment of adults with diabetes mellitus to improve glycemic control [Internet].​Insulin Icodec (Awiqli): CADTH Reimbursement Recommendation: Indication: For the once-weekly treatment of adults with diabetes mellitus to improve glycemic control [Internet].

By /

CADTH recommends that Awiqli be reimbursed by public drug plans for the once-weekly treatment of adults with type 2 diabetes mellitus (T2DM) to improve glycemic control if certain conditions are met.

​ 

Leave a Comment

Your email address will not be published. Required fields are marked *

Useful Links

NEWREDMARS SKILL AND RESEARCH        FOUNDATION

Registration No: 771800548      Contact Number : +91-8249516996

©2021-2024. Newredmars Skill and Research Foundation. All Rights Reserved.

Scroll to Top